메뉴 건너뛰기




Volumn 12, Issue 13, 2011, Pages 2141-2142

Current treatment for nonalcoholic fatty liver disease

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; GAMMA GLUTAMYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; URIC ACID;

EID: 80051519045     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2011.604597     Document Type: Letter
Times cited : (4)

References (5)
  • 1
    • 79960468113 scopus 로고    scopus 로고
    • Expert opinion on current therapies for nonalcoholic fatty liver disease
    • In press
    • Della Corte CD, Alisi A, Iorio R, et al. Expert opinion on current therapies for nonalcoholic fatty liver disease. Expert Opin Pharmacother 2011; In press
    • (2011) Expert Opin Pharmacother
    • Della Corte, C.D.1    Alisi, A.2    Iorio, R.3
  • 2
    • 79953880237 scopus 로고    scopus 로고
    • Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?
    • Athyros VG, Tziomalos K, Daskalopoulos GN, et al. Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone? Ann Med 2011;12:167-71
    • (2011) Ann Med , vol.12 , pp. 167-171
    • Athyros, V.G.1    Tziomalos, K.2    Daskalopoulos, G.N.3
  • 3
    • 78649890465 scopus 로고    scopus 로고
    • Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: A post-hoc analysis
    • GREACE Study Collaborative Group
    • Athyros VG, Tziomalos K, Gossios TD, et al.; GREACE Study Collaborative Group. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: A post-hoc analysis. Lancet 2010;376:1916-22
    • (2010) Lancet , vol.376 , pp. 1916-1922
    • Athyros, V.G.1    Tziomalos, K.2    Gossios, T.D.3
  • 5
    • 79960411842 scopus 로고    scopus 로고
    • Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): A relationship with implications for vascular risk?
    • Epub ahead of print]
    • Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): A relationship with implications for vascular risk? Curr Vasc Pharmacol 2011. [Epub ahead of print]
    • (2011) Curr Vasc Pharmacol
    • Katsiki, N.1    Athyros, V.G.2    Karagiannis, A.3    Mikhailidis, D.P.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.